SUMMER / 2009

Features

Conquering Cancer & the ClassroomReorienting kids to their academic and social lives after cancer.

BY SCOTT WILLIAMS

Targeted Therapy: Hope or Hype?The promise and reality of targeted cancer drugs.

BY LAURA BEIL

Reining in Renal CancerAre we closer to treating advanced kidney cancer as a chronic disease?

BY KAREN PATTERSON

Contents

Breaking News

ASCO UpdatesNews from the 2009 annual meeting of the American Society of Clinical Oncology.

BY STAFF REPORTS

First Line

People, News & Events

EDITED BY ELIZABETH WHITTINGTON

Diagnosis Cancer

No I.D.Treating cancer is a tricky matter when the type is unknown.

BY KATY HUMAN

Finding Hope

Disjointed CustodyLegal issues can complicate fertility preservation.

BY CHARLOTTE HUFF

Moving On

Fighting FatigueExercise restores energy to fatigued survivors.

BY LENA HUANG

Healing Well

Reconstruction Do-OversBreast reconstructions may need to be redone years later.

BY KATHY LATOUR

Caregivers' Corner

Hard TimesHow to manage the financial impact of caregiving.

BY JOANNE KENEN

In Every Issue

Editor's Page

Message from the EditorHave targeted therapies lived up to our expectations?

BY DEBU TRIPATHY, MD

Letters from Our Readers

Letters from Our ReadersReaders respond to past articles.

Side Note

All Is Not LostPlanning ahead for treatment-related hair loss.

BY LACEY MEYER

Special Report

Medical Devices Face Stricter RegulationsThe Government Accountability Office recently chastised the FDA for not moving fast enough in implementing stricter regulationsin approving Class III medical devices.

BY JO CAVALLO

Food for Thought

Good GrillingHow to avoid carcinogens on the barbecue.

BY LENA HUANG

Readers' Forum

A Life Beyond CancerCURE chooses the winning essay for it 2009 Extraordinary Healer Award for Oncology Nursing.

BY RENÉE LA FOREST

Drugs in the News

Prostate, Brain & Kidney CancersNew drug therapies aid in the treatment of prostate cancer, glioblastoma, and renal cell carcinoma.

BY ELIZABETH WHITTINGTON

Speaking Out

Revisiting the Seasons of SurvivalApplying new wisdom to the phases of survivorship.

BY KENNETH D. MILLER, MD

CONTENTS

Hair Loss Snapshot

BY LACEY MEYER

RELATED ARTICLES

 

 

Drugs Most Likely to Cause Hair Loss:

> Adriamycin (doxorubicin) 
> Camptosar (irinotecan)
> Cytoxan (cyclophosphamide)
> Ellence (epirubicin)
> Taxol (paclitaxel)
> Taxotere (docetaxel)

Drugs Least Likely to Cause Hair Loss:

> Erbitux (cetuximab)
> Faslodex (fulvestrant)
> Gemzar (gemcitabine)
> Gleevec (imatinib)
> Herceptin (trastuzumab)
> Sutent (sunitinib)
> Tamoxifen
> Tarceva (erlotinib)
> Tykerb (lapatinib)
> Xeloda (capecitabine)

^ TOP OF PAGE